Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Adrenergic signaling in cardiomyocytes
| Losmapimod | 113 [2] 113, 222 💬1. Adrenergic signaling in cardiomyocytes
|
||||||||||||||
| 2 | Adrenergic signaling in cardiomyocytes 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Adrenergic signaling in cardiomyocytes
| Neflamapimod | 008 [1] 8 💬2. Adrenergic signaling in cardiomyocytes
|
||||||||||||||
| 3 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬AGE-RAGE signaling pathway in diabetic complications
| Losmapimod | 113 [2] 113, 222 💬3. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||
| 4 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬AGE-RAGE signaling pathway in diabetic complications
| Neflamapimod | 008 [1] 8 💬4. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||
| 5 | Alcoholic liver disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Alcoholic liver disease
| Losmapimod | 113 [2] 113, 222 💬5. Alcoholic liver disease
|
||||||||||||||
| 6 | Alcoholic liver disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Alcoholic liver disease
| Neflamapimod | 008 [1] 8 💬6. Alcoholic liver disease
|
||||||||||||||
| 7 | Amyotrophic lateral sclerosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Amyotrophic lateral sclerosis
| Losmapimod | 113 [2] 113, 222 💬7. Amyotrophic lateral sclerosis
|
||||||||||||||
| 8 | Amyotrophic lateral sclerosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Amyotrophic lateral sclerosis
| Neflamapimod | 008 [1] 8 💬8. Amyotrophic lateral sclerosis
|
||||||||||||||
| 9 | C-type lectin receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬C-type lectin receptor signaling pathway
| Losmapimod | 113 [2] 113, 222 💬9. C-type lectin receptor signaling pathway
|
||||||||||||||
| 10 | C-type lectin receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬C-type lectin receptor signaling pathway
| Neflamapimod | 008 [1] 8 💬10. C-type lectin receptor signaling pathway
|
||||||||||||||
| 11 | Cellular senescence 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Cellular senescence
| Losmapimod | 113 [2] 113, 222 💬11. Cellular senescence
|
||||||||||||||
| 12 | Cellular senescence 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Cellular senescence
| Neflamapimod | 008 [1] 8 💬12. Cellular senescence
|
||||||||||||||
| 13 | Chagas disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Chagas disease
| Losmapimod | 113 [2] 113, 222 💬13. Chagas disease
|
||||||||||||||
| 14 | Chagas disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Chagas disease
| Neflamapimod | 008 [1] 8 💬14. Chagas disease
|
||||||||||||||
| 15 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Chemical carcinogenesis - reactive oxygen species
| Losmapimod | 113 [2] 113, 222 💬15. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||
| 16 | Chemical carcinogenesis - reactive oxygen species 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Chemical carcinogenesis - reactive oxygen species
| Neflamapimod | 008 [1] 8 💬16. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||
| 17 | Coronavirus disease - COVID-19 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Coronavirus disease - COVID-19
| Losmapimod | 113 [2] 113, 222 💬17. Coronavirus disease - COVID-19
|
||||||||||||||
| 18 | Coronavirus disease - COVID-19 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Coronavirus disease - COVID-19
| Neflamapimod | 008 [1] 8 💬18. Coronavirus disease - COVID-19
|
||||||||||||||
| 19 | Diabetic cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Diabetic cardiomyopathy
| Losmapimod | 113 [2] 113, 222 💬19. Diabetic cardiomyopathy
|
||||||||||||||
| 20 | Diabetic cardiomyopathy 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Diabetic cardiomyopathy
| Neflamapimod | 008 [1] 8 💬20. Diabetic cardiomyopathy
|
||||||||||||||
| 21 | Dopaminergic synapse 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Dopaminergic synapse
| Losmapimod | 113 [2] 113, 222 💬21. Dopaminergic synapse
|
||||||||||||||
| 22 | Dopaminergic synapse 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Dopaminergic synapse
| Neflamapimod | 008 [1] 8 💬22. Dopaminergic synapse
|
||||||||||||||
| 23 | Efferocytosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Efferocytosis
| Losmapimod | 113 [2] 113, 222 💬23. Efferocytosis
|
||||||||||||||
| 24 | Efferocytosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Efferocytosis
| Neflamapimod | 008 [1] 8 💬24. Efferocytosis
|
||||||||||||||
| 25 | Epithelial cell signaling in Helicobacter pylori infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Epithelial cell signaling in Helicobacter pylori infection
| Losmapimod | 113 [2] 113, 222 💬25. Epithelial cell signaling in Helicobacter pylori infection
|
||||||||||||||
| 26 | Epithelial cell signaling in Helicobacter pylori infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Epithelial cell signaling in Helicobacter pylori infection
| Neflamapimod | 008 [1] 8 💬26. Epithelial cell signaling in Helicobacter pylori infection
|
||||||||||||||
| 27 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Epstein-Barr virus infection
| Losmapimod | 113 [2] 113, 222 💬27. Epstein-Barr virus infection
|
||||||||||||||
| 28 | Epstein-Barr virus infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Epstein-Barr virus infection
| Neflamapimod | 008 [1] 8 💬28. Epstein-Barr virus infection
|
||||||||||||||
| 29 | Fc epsilon RI signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Fc epsilon RI signaling pathway
| Losmapimod | 113 [2] 113, 222 💬29. Fc epsilon RI signaling pathway
|
||||||||||||||
| 30 | Fc epsilon RI signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Fc epsilon RI signaling pathway
| Neflamapimod | 008 [1] 8 💬30. Fc epsilon RI signaling pathway
|
||||||||||||||
| 31 | Fluid shear stress and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Fluid shear stress and atherosclerosis
| Losmapimod | 113 [2] 113, 222 💬31. Fluid shear stress and atherosclerosis
|
||||||||||||||
| 32 | Fluid shear stress and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Fluid shear stress and atherosclerosis
| Neflamapimod | 008 [1] 8 💬32. Fluid shear stress and atherosclerosis
|
||||||||||||||
| 33 | FoxO signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬FoxO signaling pathway
| Losmapimod | 113 [2] 113, 222 💬33. FoxO signaling pathway
|
||||||||||||||
| 34 | FoxO signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬FoxO signaling pathway
| Neflamapimod | 008 [1] 8 💬34. FoxO signaling pathway
|
||||||||||||||
| 35 | GnRH signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬GnRH signaling pathway
| Losmapimod | 113 [2] 113, 222 💬35. GnRH signaling pathway
|
||||||||||||||
| 36 | GnRH signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬GnRH signaling pathway
| Neflamapimod | 008 [1] 8 💬36. GnRH signaling pathway
|
||||||||||||||
| 37 | Growth hormone synthesis, secretion and action 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Growth hormone synthesis, secretion and action
| Losmapimod | 113 [2] 113, 222 💬37. Growth hormone synthesis, secretion and action
|
||||||||||||||
| 38 | Growth hormone synthesis, secretion and action 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Growth hormone synthesis, secretion and action
| Neflamapimod | 008 [1] 8 💬38. Growth hormone synthesis, secretion and action
|
||||||||||||||
| 39 | Hepatitis B 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Hepatitis B
| Losmapimod | 113 [2] 113, 222 💬39. Hepatitis B
|
||||||||||||||
| 40 | Hepatitis B 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Hepatitis B
| Neflamapimod | 008 [1] 8 💬40. Hepatitis B
|
||||||||||||||
| 41 | Human cytomegalovirus infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Human cytomegalovirus infection
| Losmapimod | 113 [2] 113, 222 💬41. Human cytomegalovirus infection
|
||||||||||||||
| 42 | Human cytomegalovirus infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Human cytomegalovirus infection
| Neflamapimod | 008 [1] 8 💬42. Human cytomegalovirus infection
|
||||||||||||||
| 43 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Human immunodeficiency virus 1 infection
| Losmapimod | 113 [2] 113, 222 💬43. Human immunodeficiency virus 1 infection
|
||||||||||||||
| 44 | Human immunodeficiency virus 1 infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Human immunodeficiency virus 1 infection
| Neflamapimod | 008 [1] 8 💬44. Human immunodeficiency virus 1 infection
|
||||||||||||||
| 45 | IL-17 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬IL-17 signaling pathway
| Losmapimod | 113 [2] 113, 222 💬45. IL-17 signaling pathway
|
||||||||||||||
| 46 | IL-17 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬IL-17 signaling pathway
| Neflamapimod | 008 [1] 8 💬46. IL-17 signaling pathway
|
||||||||||||||
| 47 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Inflammatory mediator regulation of TRP channels
| Losmapimod | 113 [2] 113, 222 💬47. Inflammatory mediator regulation of TRP channels
|
||||||||||||||
| 48 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Inflammatory mediator regulation of TRP channels
| Neflamapimod | 008 [1] 8 💬48. Inflammatory mediator regulation of TRP channels
|
||||||||||||||
| 49 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Kaposi sarcoma-associated herpesvirus infection
| Losmapimod | 113 [2] 113, 222 💬49. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||
| 50 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Kaposi sarcoma-associated herpesvirus infection
| Neflamapimod | 008 [1] 8 💬50. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||
| 51 | Leishmaniasis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Leishmaniasis
| Losmapimod | 113 [2] 113, 222 💬51. Leishmaniasis
|
||||||||||||||
| 52 | Leishmaniasis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Leishmaniasis
| Neflamapimod | 008 [1] 8 💬52. Leishmaniasis
|
||||||||||||||
| 53 | Leukocyte transendothelial migration 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Leukocyte transendothelial migration
| Losmapimod | 113 [2] 113, 222 💬53. Leukocyte transendothelial migration
|
||||||||||||||
| 54 | Leukocyte transendothelial migration 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Leukocyte transendothelial migration
| Neflamapimod | 008 [1] 8 💬54. Leukocyte transendothelial migration
|
||||||||||||||
| 55 | Lipid and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Lipid and atherosclerosis
| Losmapimod | 113 [2] 113, 222 💬55. Lipid and atherosclerosis
|
||||||||||||||
| 56 | Lipid and atherosclerosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Lipid and atherosclerosis
| Neflamapimod | 008 [1] 8 💬56. Lipid and atherosclerosis
|
||||||||||||||
| 57 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬MAPK signaling pathway
| Losmapimod | 113 [2] 113, 222 💬57. MAPK signaling pathway
|
||||||||||||||
| 58 | MAPK signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬MAPK signaling pathway
| Neflamapimod | 008 [1] 8 💬58. MAPK signaling pathway
|
||||||||||||||
| 59 | Neurotrophin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Neurotrophin signaling pathway
| Losmapimod | 113 [2] 113, 222 💬59. Neurotrophin signaling pathway
|
||||||||||||||
| 60 | Neurotrophin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Neurotrophin signaling pathway
| Neflamapimod | 008 [1] 8 💬60. Neurotrophin signaling pathway
|
||||||||||||||
| 61 | Neutrophil extracellular trap formation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Neutrophil extracellular trap formation
| Losmapimod | 113 [2] 113, 222 💬61. Neutrophil extracellular trap formation
|
||||||||||||||
| 62 | Neutrophil extracellular trap formation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Neutrophil extracellular trap formation
| Neflamapimod | 008 [1] 8 💬62. Neutrophil extracellular trap formation
|
||||||||||||||
| 63 | NOD-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬NOD-like receptor signaling pathway
| Losmapimod | 113 [2] 113, 222 💬63. NOD-like receptor signaling pathway
|
||||||||||||||
| 64 | NOD-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬NOD-like receptor signaling pathway
| Neflamapimod | 008 [1] 8 💬64. NOD-like receptor signaling pathway
|
||||||||||||||
| 65 | Non-alcoholic fatty liver disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Non-alcoholic fatty liver disease
| Losmapimod | 113 [2] 113, 222 💬65. Non-alcoholic fatty liver disease
|
||||||||||||||
| 66 | Non-alcoholic fatty liver disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Non-alcoholic fatty liver disease
| Neflamapimod | 008 [1] 8 💬66. Non-alcoholic fatty liver disease
|
||||||||||||||
| 67 | Oocyte meiosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Oocyte meiosis
| Losmapimod | 113 [2] 113, 222 💬67. Oocyte meiosis
|
||||||||||||||
| 68 | Oocyte meiosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Oocyte meiosis
| Neflamapimod | 008 [1] 8 💬68. Oocyte meiosis
|
||||||||||||||
| 69 | Osteoclast differentiation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Osteoclast differentiation
| Losmapimod | 113 [2] 113, 222 💬69. Osteoclast differentiation
|
||||||||||||||
| 70 | Osteoclast differentiation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Osteoclast differentiation
| Neflamapimod | 008 [1] 8 💬70. Osteoclast differentiation
|
||||||||||||||
| 71 | Pathogenic Escherichia coli infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Pathogenic Escherichia coli infection
| Losmapimod | 113 [2] 113, 222 💬71. Pathogenic Escherichia coli infection
|
||||||||||||||
| 72 | Pathogenic Escherichia coli infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Pathogenic Escherichia coli infection
| Neflamapimod | 008 [1] 8 💬72. Pathogenic Escherichia coli infection
|
||||||||||||||
| 73 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Pathways of neurodegeneration - multiple diseases
| Losmapimod | 113 [2] 113, 222 💬73. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||
| 74 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Pathways of neurodegeneration - multiple diseases
| Neflamapimod | 008 [1] 8 💬74. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||
| 75 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Losmapimod | 113 [2] 113, 222 💬75. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||
| 76 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Neflamapimod | 008 [1] 8 💬76. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||
| 77 | Pertussis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Pertussis
| Losmapimod | 113 [2] 113, 222 💬77. Pertussis
|
||||||||||||||
| 78 | Pertussis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Pertussis
| Neflamapimod | 008 [1] 8 💬78. Pertussis
|
||||||||||||||
| 79 | Platelet activation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Platelet activation
| Losmapimod | 113 [2] 113, 222 💬79. Platelet activation
|
||||||||||||||
| 80 | Platelet activation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Platelet activation
| Neflamapimod | 008 [1] 8 💬80. Platelet activation
|
||||||||||||||
| 81 | Prion disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Prion disease
| Losmapimod | 113 [2] 113, 222 💬81. Prion disease
|
||||||||||||||
| 82 | Prion disease 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Prion disease
| Neflamapimod | 008 [1] 8 💬82. Prion disease
|
||||||||||||||
| 83 | Progesterone-mediated oocyte maturation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Progesterone-mediated oocyte maturation
| Losmapimod | 113 [2] 113, 222 💬83. Progesterone-mediated oocyte maturation
|
||||||||||||||
| 84 | Progesterone-mediated oocyte maturation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Progesterone-mediated oocyte maturation
| Neflamapimod | 008 [1] 8 💬84. Progesterone-mediated oocyte maturation
|
||||||||||||||
| 85 | Prolactin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Prolactin signaling pathway
| Losmapimod | 113 [2] 113, 222 💬85. Prolactin signaling pathway
|
||||||||||||||
| 86 | Prolactin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Prolactin signaling pathway
| Neflamapimod | 008 [1] 8 💬86. Prolactin signaling pathway
|
||||||||||||||
| 87 | Proteoglycans in cancer 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Proteoglycans in cancer
| Losmapimod | 113 [2] 113, 222 💬87. Proteoglycans in cancer
|
||||||||||||||
| 88 | Proteoglycans in cancer 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Proteoglycans in cancer
| Neflamapimod | 008 [1] 8 💬88. Proteoglycans in cancer
|
||||||||||||||
| 89 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Rap1 signaling pathway
| Losmapimod | 113 [2] 113, 222 💬89. Rap1 signaling pathway
|
||||||||||||||
| 90 | Rap1 signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Rap1 signaling pathway
| Neflamapimod | 008 [1] 8 💬90. Rap1 signaling pathway
|
||||||||||||||
| 91 | Relaxin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Relaxin signaling pathway
| Losmapimod | 113 [2] 113, 222 💬91. Relaxin signaling pathway
|
||||||||||||||
| 92 | Relaxin signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Relaxin signaling pathway
| Neflamapimod | 008 [1] 8 💬92. Relaxin signaling pathway
|
||||||||||||||
| 93 | Retrograde endocannabinoid signaling 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Retrograde endocannabinoid signaling
| Losmapimod | 113 [2] 113, 222 💬93. Retrograde endocannabinoid signaling
|
||||||||||||||
| 94 | Retrograde endocannabinoid signaling 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Retrograde endocannabinoid signaling
| Neflamapimod | 008 [1] 8 💬94. Retrograde endocannabinoid signaling
|
||||||||||||||
| 95 | RIG-I-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬RIG-I-like receptor signaling pathway
| Losmapimod | 113 [2] 113, 222 💬95. RIG-I-like receptor signaling pathway
|
||||||||||||||
| 96 | RIG-I-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬RIG-I-like receptor signaling pathway
| Neflamapimod | 008 [1] 8 💬96. RIG-I-like receptor signaling pathway
|
||||||||||||||
| 97 | Salmonella infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Salmonella infection
| Losmapimod | 113 [2] 113, 222 💬97. Salmonella infection
|
||||||||||||||
| 98 | Salmonella infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Salmonella infection
| Neflamapimod | 008 [1] 8 💬98. Salmonella infection
|
||||||||||||||
| 99 | Shigellosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Shigellosis
| Losmapimod | 113 [2] 113, 222 💬99. Shigellosis
|
||||||||||||||
| 100 | Shigellosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Shigellosis
| Neflamapimod | 008 [1] 8 💬100. Shigellosis
|
||||||||||||||
| 101 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Signaling pathways regulating pluripotency of stem cells
| Losmapimod | 113 [2] 113, 222 💬101. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||
| 102 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Signaling pathways regulating pluripotency of stem cells
| Neflamapimod | 008 [1] 8 💬102. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||
| 103 | Sphingolipid signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Sphingolipid signaling pathway
| Losmapimod | 113 [2] 113, 222 💬103. Sphingolipid signaling pathway
|
||||||||||||||
| 104 | Sphingolipid signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Sphingolipid signaling pathway
| Neflamapimod | 008 [1] 8 💬104. Sphingolipid signaling pathway
|
||||||||||||||
| 105 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬T cell receptor signaling pathway
| Losmapimod | 113 [2] 113, 222 💬105. T cell receptor signaling pathway
|
||||||||||||||
| 106 | T cell receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬T cell receptor signaling pathway
| Neflamapimod | 008 [1] 8 💬106. T cell receptor signaling pathway
|
||||||||||||||
| 107 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Th1 and Th2 cell differentiation
| Losmapimod | 113 [2] 113, 222 💬107. Th1 and Th2 cell differentiation
|
||||||||||||||
| 108 | Th1 and Th2 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Th1 and Th2 cell differentiation
| Neflamapimod | 008 [1] 8 💬108. Th1 and Th2 cell differentiation
|
||||||||||||||
| 109 | Th17 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Th17 cell differentiation
| Losmapimod | 113 [2] 113, 222 💬109. Th17 cell differentiation
|
||||||||||||||
| 110 | Th17 cell differentiation 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Th17 cell differentiation
| Neflamapimod | 008 [1] 8 💬110. Th17 cell differentiation
|
||||||||||||||
| 111 | Thermogenesis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Thermogenesis
| Losmapimod | 113 [2] 113, 222 💬111. Thermogenesis
|
||||||||||||||
| 112 | Thermogenesis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Thermogenesis
| Neflamapimod | 008 [1] 8 💬112. Thermogenesis
|
||||||||||||||
| 113 | TNF signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬TNF signaling pathway
| Losmapimod | 113 [2] 113, 222 💬113. TNF signaling pathway
|
||||||||||||||
| 114 | TNF signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬TNF signaling pathway
| Neflamapimod | 008 [1] 8 💬114. TNF signaling pathway
|
||||||||||||||
| 115 | Toll-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Toll-like receptor signaling pathway
| Losmapimod | 113 [2] 113, 222 💬115. Toll-like receptor signaling pathway
|
||||||||||||||
| 116 | Toll-like receptor signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Toll-like receptor signaling pathway
| Neflamapimod | 008 [1] 8 💬116. Toll-like receptor signaling pathway
|
||||||||||||||
| 117 | Toxoplasmosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Toxoplasmosis
| Losmapimod | 113 [2] 113, 222 💬117. Toxoplasmosis
|
||||||||||||||
| 118 | Toxoplasmosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Toxoplasmosis
| Neflamapimod | 008 [1] 8 💬118. Toxoplasmosis
|
||||||||||||||
| 119 | Tuberculosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Tuberculosis
| Losmapimod | 113 [2] 113, 222 💬119. Tuberculosis
|
||||||||||||||
| 120 | Tuberculosis 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Tuberculosis
| Neflamapimod | 008 [1] 8 💬120. Tuberculosis
|
||||||||||||||
| 121 | VEGF signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬VEGF signaling pathway
| Losmapimod | 113 [2] 113, 222 💬121. VEGF signaling pathway
|
||||||||||||||
| 122 | VEGF signaling pathway 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬VEGF signaling pathway
| Neflamapimod | 008 [1] 8 💬122. VEGF signaling pathway
|
||||||||||||||
| 123 | Yersinia infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Losmapimod Losmapimod 💬Yersinia infection
| Losmapimod | 113 [2] 113, 222 💬123. Yersinia infection
|
||||||||||||||
| 124 | Yersinia infection 💬 1 gene, 2 drugs (DrugBank) and 3 diseases |
MAPK13 [1] MAPK13 💬Adrenergic signaling in cardiomyocytes
|
Neflamapimod Neflamapimod 💬Yersinia infection
| Neflamapimod | 008 [1] 8 💬124. Yersinia infection
|
Adrenergic signaling in cardiomyocytes
1 gene, 2 drugs (DrugBank) and 3 diseases
AGE-RAGE signaling pathway in diabetic complications
1 gene, 2 drugs (DrugBank) and 3 diseases
Alcoholic liver disease
1 gene, 2 drugs (DrugBank) and 3 diseases
Amyotrophic lateral sclerosis
1 gene, 2 drugs (DrugBank) and 3 diseases
C-type lectin receptor signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Cellular senescence
1 gene, 2 drugs (DrugBank) and 3 diseases
Chagas disease
1 gene, 2 drugs (DrugBank) and 3 diseases
Chemical carcinogenesis - reactive oxygen species
1 gene, 2 drugs (DrugBank) and 3 diseases
Coronavirus disease - COVID-19
1 gene, 2 drugs (DrugBank) and 3 diseases
Diabetic cardiomyopathy
1 gene, 2 drugs (DrugBank) and 3 diseases
Dopaminergic synapse
1 gene, 2 drugs (DrugBank) and 3 diseases
Efferocytosis
1 gene, 2 drugs (DrugBank) and 3 diseases
Epithelial cell signaling in Helicobacter pylori infection
1 gene, 2 drugs (DrugBank) and 3 diseases
Epstein-Barr virus infection
1 gene, 2 drugs (DrugBank) and 3 diseases
Fc epsilon RI signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Fluid shear stress and atherosclerosis
1 gene, 2 drugs (DrugBank) and 3 diseases
FoxO signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
GnRH signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Growth hormone synthesis, secretion and action
1 gene, 2 drugs (DrugBank) and 3 diseases
Hepatitis B
1 gene, 2 drugs (DrugBank) and 3 diseases
Human cytomegalovirus infection
1 gene, 2 drugs (DrugBank) and 3 diseases
Human immunodeficiency virus 1 infection
1 gene, 2 drugs (DrugBank) and 3 diseases
IL-17 signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Inflammatory mediator regulation of TRP channels
1 gene, 2 drugs (DrugBank) and 3 diseases
Kaposi sarcoma-associated herpesvirus infection
1 gene, 2 drugs (DrugBank) and 3 diseases
Leishmaniasis
1 gene, 2 drugs (DrugBank) and 3 diseases
Leukocyte transendothelial migration
1 gene, 2 drugs (DrugBank) and 3 diseases
Lipid and atherosclerosis
1 gene, 2 drugs (DrugBank) and 3 diseases
MAPK signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Neurotrophin signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Neutrophil extracellular trap formation
1 gene, 2 drugs (DrugBank) and 3 diseases
NOD-like receptor signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Non-alcoholic fatty liver disease
1 gene, 2 drugs (DrugBank) and 3 diseases
Oocyte meiosis
1 gene, 2 drugs (DrugBank) and 3 diseases
Osteoclast differentiation
1 gene, 2 drugs (DrugBank) and 3 diseases
Pathogenic Escherichia coli infection
1 gene, 2 drugs (DrugBank) and 3 diseases
Pathways of neurodegeneration - multiple diseases
1 gene, 2 drugs (DrugBank) and 3 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
1 gene, 2 drugs (DrugBank) and 3 diseases
Pertussis
1 gene, 2 drugs (DrugBank) and 3 diseases
Platelet activation
1 gene, 2 drugs (DrugBank) and 3 diseases
Prion disease
1 gene, 2 drugs (DrugBank) and 3 diseases
Progesterone-mediated oocyte maturation
1 gene, 2 drugs (DrugBank) and 3 diseases
Prolactin signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Proteoglycans in cancer
1 gene, 2 drugs (DrugBank) and 3 diseases
Rap1 signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Relaxin signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Retrograde endocannabinoid signaling
1 gene, 2 drugs (DrugBank) and 3 diseases
RIG-I-like receptor signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Salmonella infection
1 gene, 2 drugs (DrugBank) and 3 diseases
Shigellosis
1 gene, 2 drugs (DrugBank) and 3 diseases
Signaling pathways regulating pluripotency of stem cells
1 gene, 2 drugs (DrugBank) and 3 diseases
Sphingolipid signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
T cell receptor signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Th1 and Th2 cell differentiation
1 gene, 2 drugs (DrugBank) and 3 diseases
Th17 cell differentiation
1 gene, 2 drugs (DrugBank) and 3 diseases
Thermogenesis
1 gene, 2 drugs (DrugBank) and 3 diseases
TNF signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Toll-like receptor signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Toxoplasmosis
1 gene, 2 drugs (DrugBank) and 3 diseases
Tuberculosis
1 gene, 2 drugs (DrugBank) and 3 diseases
VEGF signaling pathway
1 gene, 2 drugs (DrugBank) and 3 diseases
Yersinia infection
1 gene, 2 drugs (DrugBank) and 3 diseases
